QUOTE AND NEWS
DailyFinance  Sep 10  Comment 
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and ICON plc, (NASDAQ:ICLR) a global provider of outsourced development services to the...
SeekingAlpha  Aug 7  Comment 
By Fundamental Contrarian: Medidata (NASDAQ:MDSO) and other growth, centrally-hosted licensed software (aka SaaS aka Cloud) companies typically have little to no net income and typically trade on revenue multiples. Around the time the general...
TheStreet.com  Aug 5  Comment 
NEW YORK (TheStreet) -- Good luck traders! Today's top swing trade picks are Darden Restaurants , Medidata Solutions and Zebra Technologies . Read More: A Simple Options Trading Strategy That Beats the S&P 500 1. First let's look at Darden...
DailyFinance  Aug 4  Comment 
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Cory Douglas, chief financial officer, will present at the Annual Needham Interconnect ...
DailyFinance  Aug 1  Comment 
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, is pleased to announce that Michelle Marlborough, the company’s vice president of product strategy, has...
Cloud Computing  Jul 30  Comment 
Sumo Logic, the next generation machine data intelligence company, today announced Medidata has selected the company and The Herjavec Group (THG) to advance the organization's security and compliance initiatives. Medidata is the leading global...
SeekingAlpha  Jul 29  Comment 
The following audio is from a conference call that will begin on July 29, 2014 at 08:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen now Complete Story »
Cloud Computing  Jul 29  Comment 
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the second quarter of 2014 and reiterated its revenue ...
Motley Fool  Jul 25  Comment 
Whether you have a short, medium, or long-term time horizon, there's something to watch when this cloud company reports
Cloud Computing  Jun 23  Comment 
Companies, and entire industries, today face a choice between radical change—often involving the reinvention of a business model—and imminent obsolescence. Yet, despite the life-or-death stakes, only 50% of executives say...




RELATED WIKI ARTICLES
 
TOP CONTRIBUTORS
Medidata Solutions (NASDAQ:MDSO) sells a software platform called Medidata Rave that helps biotech and pharmaceutical companies enhance the efficiency of their clinical development processes.[1] It achieves this by integrating electronic data capture (EDC) with a clinical data management system (CDMS) in a single product.
Medidata Rave is a comprehensive platform that replaces traditional paper-based methods of capturing and managing clinical data.
Medidata Rave is a comprehensive platform that replaces traditional paper-based methods of capturing and managing clinical data.
The company also sells a protocol authoring tool (Medidata Designer), a grant management system (Medidata Grant Manager) and a CRO contracting platform (Medidata CRO Contractor). In 2007, 2008 and the first quarter of 2009, the company's top five customers by revenue were Johnson & Johnson, AstraZeneca, Amgen, Astellas Pharma and Takeda Pharmaceutical.[1]

Medidata's initial public offering (IPO) of stock is scheduled for 18 June 2009. It plans to sell 6.3 million shares at between $11 and $12 per share. In 2008, the company had $106 million in total revenues, up 67.9% from $63.0 million in 2007. However, it still made a net loss of $18.3 million, down 22.8% from the $23.7 million net loss made in 2007.[2] In the same year, 69% of revenues came from customers in the United States, 21% from Europe and 10% from Asia (including Australia). In the first quarter of 2009, the company had $33.6 million in total revenues, up 60.2% from $21.0 million in the same quarter of the 2008.[2] It also had $1.7 million in net income, up 120% from the $8.6 million net loss made in 2007. Existing investors in the company include Insight Venture Partners (33.9%), chief executive officer and chairman Tarek Sherif (9.0%), president and director Glen M. de Vries (9.0%) and Milestone Venture Partners (7.6%).

References

  1. 1.0 1.1 Business, 2009 MDSO S-1/A
  2. 2.0 2.1 Selected Consolidated Financial Information, 2009 MDSO S-1/A
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki